BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 24637863)

  • 41. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection.
    Chhabra D; Grafals M; Skaro AI; Parker M; Gallon L
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1168-74. PubMed ID: 18463170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum IL-6 predicts risk of kidney transplant failure independently of immunological risk.
    Friedmann J; Schuster A; Reichelt-Wurm S; Banas B; Bergler T; Steines L
    Transpl Immunol; 2024 Jun; 84():102043. PubMed ID: 38548029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research Consortium.
    Ashoor IF; Engen RM; Puliyanda D; Hayde N; Peterson CG; Zahr RS; Solomon S; Kallash M; Garro R; Jain A; Harshman LA; McEwen ST; Mansuri A; Gregoski MJ; Twombley KE
    Pediatr Transplant; 2024 May; 28(3):e14734. PubMed ID: 38602171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients.
    Lorenz M; Regele H; Schillinger M; Kletzmayr J; Haidbauer B; Derfler K; Druml W; Böhmig GA
    Transplantation; 2005 Mar; 79(6):696-701. PubMed ID: 15785376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cadaveric renal transplantation with quadruple immunosuppression in patients with a positive antiglobulin crossmatch.
    Stratta RJ; Mason B; Lorentzen DF; Sollinger HW; D'Alessandro AM; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1989 Feb; 47(2):282-6. PubMed ID: 2645713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for renal allograft survival in patients receiving cyclosporine immunosuppression.
    Hsieh HH; Chien YS; Hsu KT; Chung HM; Huang HF
    J Formos Med Assoc; 2000 Jun; 99(6):453-8. PubMed ID: 10925550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of B cell alloantibodies to renal allograft survival.
    Mohanakumar T; Giedlin MA; Rhodes CL; DuVall CH; Mendez-Picon G; Kaplan AM; Lee HM
    Transplantation; 1979 Apr; 27(4):273-8. PubMed ID: 375503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.
    Bynum JP; Zachary A; Ness PM; Luo X; Bagnasco S; King KE; Segev DL; Orandi BJ; Warren DS; Fuller A; Ciappi A; Montgomery R; Tobian AAR
    Transfusion; 2018 Aug; 58(8):1951-1957. PubMed ID: 30171817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies.
    Mantell BS; Cordero H; See SB; Clerkin KJ; Vasilescu R; Marboe CC; Naka Y; Restaino S; Colombo PC; Addonizio LJ; Farr MA; Zorn E
    J Heart Lung Transplant; 2021 Nov; 40(11):1472-1480. PubMed ID: 34420852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute graft pyelonephritis and long-term kidney allograft outcome.
    Giral M; Pascuariello G; Karam G; Hourmant M; Cantarovich D; Dantal J; Blancho G; Coupel S; Josien R; Daguin P; Méchineau S; Soulillou JP
    Kidney Int; 2002 May; 61(5):1880-6. PubMed ID: 11967040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early versus late acute renal allograft rejection: impact on chronic rejection.
    Basadonna GP; Matas AJ; Gillingham KJ; Payne WD; Dunn DL; Sutherland DE; Gores PF; Gruessner RW; Najarian JS
    Transplantation; 1993 May; 55(5):993-5. PubMed ID: 8497913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.
    Banham G; Prezzi D; Harford S; Taylor CJ; Hamer R; Higgins R; Bradley JA; Clatworthy MR
    Transplantation; 2013 Aug; 96(4):413-20. PubMed ID: 23842189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.
    Dumortier J; Conti F; Hiriart JB; Dharancy S; Duvoux C; Besch C; Houssel-Debry P; Latournerie M; Chermak F; Meszaros M; Pageaux GP; Radenne S; Boillot O; Hardwigsen J; Kounis I; Kamar N; Saliba F; Erard D; Del Bello A
    Liver Transpl; 2023 Dec; 29(12):1313-1322. PubMed ID: 37367954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of time from transplantation to biopsy in histologic ABMR: A single center report.
    Chancay J; Liu C; Chauhan K; Andersen L; Harris C; Coca S; Delaney V; Tedla F; De Boccardo G; Sehgal V; Moledina D; Formica R; Reghuvaran A; Banu K; Florman S; Akalin E; Shapiro R; Salem F; Menon MC
    Clin Transplant; 2022 Dec; 36(12):e14802. PubMed ID: 36069577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts.
    Messias NC; Eustace JA; Zachary AA; Tucker PC; Charney D; Racusen LC
    Transplantation; 2001 Aug; 72(4):655-60. PubMed ID: 11544426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bortezomib for antibody-mediated rejection of kidney transplant in youth: Associations with donor-specific antibody.
    Fulchiero R; Galea L; Hewlett J; Savant JD; Lopez S; Amaral S; Viteri B
    Pediatr Transplant; 2024 Aug; 28(5):e14774. PubMed ID: 38808699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody-mediated rejection following renal transplantation.
    Sureshkumar KK; Hussain SM; Carpenter BJ; Sandroni SE; Marcus RJ
    Expert Opin Pharmacother; 2007 May; 8(7):913-21. PubMed ID: 17472537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients.
    Lietz K; John R; Kocher A; Schuster M; Mancini DM; Edwards NM; Itescu S
    Circulation; 2001 Sep; 104(12 Suppl 1):I177-83. PubMed ID: 11568052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Transient and Persistent Donor-Specific Antibodies in Lung Transplantation.
    Auner S; Hillebrand C; Boehm PM; Boecker J; Koren D; Schwarz S; Kovacs Z; Murakoezy G; Fischer G; Aigner C; Hoetzenecker K; Jaksch P; Benazzo A
    Transpl Int; 2024; 37():12774. PubMed ID: 38779355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk Stratification for Rejection and Infection after Kidney Transplantation.
    Cippà PE; Schiesser M; Ekberg H; van Gelder T; Mueller NJ; Cao CA; Fehr T; Bernasconi C
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2213-20. PubMed ID: 26430088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.